Long-term effect of sulfionylura in permanent neonatal diabetes due to mutations in KCNJ11 encoding kir6.2

被引：0
|
作者：
Njolstad, PR
Abuelo, D
Baevre, H
Hansen, T
Hathout, E
Kirsti, A
Hogasen, M
Molven, A
Pedersen, O
Phutkul, CP
Pontynen, S
Pruhova, S
Raeder, H
Sagen, JV
Shehadeh, N
Silva, JML
Sovik, O
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A293 / A293
页数：1
相关论文
共 50 条
  • [31] Polymorphisms of KCNJ11 (Kir6.2 gene) are associated with Type 2 diabetes and hypertension in the Korean population
    Koo, B. K.
    Cho, Y. M.
    Park, B. L.
    Cheong, H. S.
    Shin, H. D.
    Jang, H. C.
    Kim, S. Y.
    Lee, H. K.
    Park, K. S.
    DIABETIC MEDICINE, 2007, 24 (02) : 178 - 186
  • [32] Transient neonatal diabetes mellitus is associated with a R50Q mutation in the Kir6.2 subunit (KCNJ11) gene
    Ioannou, S. Yiannis
    Ellard, Sian
    Hattetrsley, T. Andrew
    Scordis, Nikos
    HORMONE RESEARCH, 2008, 70 : 208 - 208
  • [33] Kir6.2 (KCNJ11) E23K variant in Type 2 diabetes in Italians
    Gragnoli, Claudia
    OBESITY AND METABOLISM-MILAN, 2007, 3 (02): : 97 - 98
  • [34] KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes
    Massa, O
    Iafusco, D
    D'Amato, E
    Gloyn, AL
    Hattersley, AT
    Pasquino, B
    Tonini, G
    Dammacco, F
    Zanette, G
    Meschi, F
    Porzio, O
    Bottazzo, G
    Crinó, A
    Lorini, R
    Cerutti, F
    Vanelli, M
    Barbetti, F
    HUMAN MUTATION, 2005, 25 (01) : 22 - 27
  • [35] Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy
    Proks, Peter
    Girard, Christophe
    Baevre, Halvor
    Njolstad, Pal R.
    Ashcroft, Frances M.
    DIABETES, 2006, 55 (06) : 1731 - 1737
  • [36] Kir6.2 mutations search in patients with permanent neonatal diabetes from a Polish population
    Klupa, T
    Flanagan, S
    Nazim, J
    Ellard, S
    Ciechanowska, M
    Starzyk, J
    Sieradzki, J
    Hattersley, AT
    Malecki, MT
    DIABETOLOGIA, 2005, 48 : A112 - A113
  • [37] Kir6.2 mutations search in patients with permanent neonatal diabetes from a Polish population
    Malecki, MT
    Klupa, T
    Flanagan, S
    Nazim, J
    Ciechanowska, M
    Starzyk, J
    Hattersley, AT
    Sieradzki, J
    DIABETES, 2005, 54 : A275 - A275
  • [38] Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2
    Zung, A
    Glaser, B
    Nimri, R
    Zadik, Z
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (11): : 5504 - 5507
  • [39] Association of the E23K polymorphism in the Kir6.2 (KCNJ11) gene with gestational diabetes mellitus
    Shaat, N
    Ekelund, M
    Lernmark, Å
    Ivarsson, S
    Almgren, P
    Berntorp, K
    Groop, L
    DIABETOLOGIA, 2005, 48 : A70 - A70
  • [40] Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study
    Bowman, Pamela
    Sulen, Asta
    Barbetti, Fabrizio
    Beltrand, Jacques
    Svalastoga, Pernille
    Codner, Ethel
    Tessmann, Ellen H.
    Juliusson, Petur B.
    Skrivarhaug, Torild
    Pearson, Ewan R.
    Flanagan, Sarah E.
    Babiker, Tarig
    Thomas, Nicholas J.
    Shepherd, Maggie H.
    Ellard, Sian
    Klimes, Iwar
    Szopa, Magdalena
    Polak, Michel
    Iafusco, Dario
    Hattersley, Andrew T.
    Njolstad, Pal R.
    Houghton, Jayne
    Patel, Kashyap Amratlal
    Mathews, Frances
    De Franco, Elisa
    Ford, Tamsin
    Pillai, Janani Kumaraguru
    Finn, Roisin
    Chakera, Ali
    Iotova, Violeta
    Malecki, Maciej T.
    Klupa, Tomasz
    Gasperikova, Daniela
    Stanik, Juraj
    Barak, Lubomir
    Dankovcikova, Adriana
    Palko, Miroslav
    Walker, Jan
    Visser, Uma
    Howard, Neville
    Lafferty, Tony
    Cummings, Elizabeth
    Guntamukkala, Padma
    Rose, Danette
    Hughes, Natalie
    Couch, Bob
    Punthakee, Zubin
    Van der Meulen, John
    LeGault, Laurent
    Sanderson, Susan
    LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (08): : 637 - 646
12345